Navigation Links
Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
Date:8/5/2008

HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond

Similarly to Men and Whites

MEXICO CITY, Aug. 5 /PRNewswire-FirstCall/ -- Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (NYSE: ABT) protease inhibitor Kaletra(R) (lopinavir/ritonavir) tablet provided similar results for controlling the virus (reducing the amount of HIV-1) and improving the immune system (increasing CD4 cells) in women compared to men and in non-whites compared to whites, according to 48-week data presented by Abbott today at the XVII International AIDS Conference (AIDS 2008).

A retrospective sub-analysis of study M05-730 at week 48 of 96 weeks offered data on the impact of gender and race on a Kaletra-based regimen. Women and non-whites have traditionally been underrepresented in HIV studies, although these patient groups increasingly account for the vast majority of HIV infections. According to the World Health Organization, by the end of 2007, 22.5 million of the total 33.2 million people infected with HIV lived in sub-Saharan Africa. Additionally, 15.4 million of the total number of HIV-infected patients worldwide are women.

"The results showed that regardless of gender or race, Kaletra dosed once-daily or twice-daily as part of a treatment regimen achieved consistent virologic suppression in patients new to antiretroviral therapy," said Scott Brun, M.D., divisional vice president, Infectious Diseases and Immunology Development, Global Pharmaceutical Research and Development, Abbott. "Additionally, the Kaletra tablet formulation is a convenient HIV treatment option that can be taken with or without food and does not require refrigeration, which is particularly important to patients in the developing world who are disproportionately affected by HIV."

M05-730 Analysis Results

Through 48 weeks, the proportions of males and females who achieved an undetectable HIV viral load wer
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
2. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
3. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
4. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
5. New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV
6. A Phase II, Randomized, Double Blind, Placebo-Controlled Dose-Escalating Study, Meets the Clinical Endpoints of MTR106 Tablets During the Treatment of Acute Migraine Attacks Without Aura in Females
7. UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets
8. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
9. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
10. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
11. Treximet(TM) (Sumatriptan and Naproxen Sodium) Tablets Approved by FDA for Acute Treatment of Migraine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 According to the ... Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications ... - Global Forecast to 2019" published by MarketsandMarkets, the ... $19,786.3 Million by 2019 from $14,240.0 Million in ... to 2019. Browse 74 market data ...
(Date:9/19/2014)... -- 4WEB Medical announces the formal launch of the ... on the market today at this weekend,s American ... Chicago .  The Osteotomy Truss System is a ... 74 size options included in one versatile set. Previously ... to 18 implant sizes, which limited a surgeon,s ability ...
(Date:9/19/2014)... 19, 2014 Merck (NYSE: MRK ), known ... Canada , is teaming with celebrity chef and ... Tus Metas , an educational program encouraging Hispanics with type 2 ... key treatment goal to help reduce the risk of serious health ... at a higher risk for developing type 2 diabetes than non-Hispanic ...
Breaking Medicine Technology:Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 44WEB Medical Unveils 3D-Printed Osteotomy Truss System 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... May 30, 2012 The use of an armband-based ... of four approaches to weight loss examined by researchers ... American College of Sports Medicine,s 59th Annual Meeting ... this week in San Francisco. The study, "An Economic ...
... -- Global Information Inc is pleased to ... research reports from Greystone Research Associates examining the ... Sprays. (Photo: http://photos.prnewswire.com/prnh/20120530/CG15754 ) ... Greystone Research Associates, new market study " ...
Cached Medicine Technology:Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 2Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 3New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets 2New Research Available on the Multi-Billion Dollar Transmucosal Drug Delivery and Systemic Nasal Sprays Markets 3
(Date:9/20/2014)... UWDress.com, a professional company of women’s dresses and related ... evening cocktail dresses . As a matter of ... very popular among worldwide customers. Now, all its evening ... 65 percent off). , All UWDress.com’s employees are ... for the global clients. The company is famous for ...
(Date:9/20/2014)... Las Vegas, NV (PRWEB) September 21, 2014 ... health improvement method developed by fitness expert Michael Wren ... finally lose stubborn weight and reverse health conditions like ... caught the attention of Shane Michaels, prompting an investigative ... weight loss methods and tips upside down by showing ...
(Date:9/20/2014)... David Cooke presented two scientific posters at ... at the clinical benefits of MPI gated studies with ... In conjunction with colleagues at Emory University, Cooke studied ... by echo (>50%). Each patient had same-day 99mTc low-dose ... Emory Toolbox 4.0 was used to analyze the ...
(Date:9/20/2014)... 20, 2014 Villa del Palmar at ... not experience any damage in relation to Hurricane Odile ... available. , Hurricane Odile struck Cabo San Lucas the ... and powerful surf conditions. Located on the east side ... Loreto experienced some heavy rain, but no damage whatsoever ...
(Date:9/20/2014)... Ticket Down is a dependable ... This popular ticket exchange is offering their customer appreciation promo ... schedule of tours is beginning to fill up. Many of ... to hit the road, including 21-year-old pop superstar, Ariana Grande. ... Tour,” which will take her to 25 cities across the ...
Breaking Medicine News(10 mins):Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 2Health News:Ariana Grande Tickets in Phoenix, Los Angeles, Anaheim, San Jose, Seattle, and Vancouver Go on Sale Today 3
... WHITE PLAINS, N.Y., Aug. 24 Out With Allergies LLC ... as a potent new weapon for combating swine flu. Available through ... t es.com , these stick-on notes are intended to make ... catching and spreading the flu. These direct message washup labels are anticipated ...
... , EUGENE, Ore., Aug. 24 The Tech-Aid ... is launching a national campaign to educate people with intellectual ... germs that include the 2009 flu pandemic that is commonly ... this virus already hitting the United States, Tech-Aid hopes to ...
... , DEERFIELD BEACH, Fla., Aug. 24 ... in a diverse range of chronic degenerative diseases. The news, recently ... may help rheumatoid arthritis or avoidance of gluten may fight off ... field," says Dr. David Heber, a UCLA professor of medicine and ...
... SHENZHEN, China, Aug. 24 /PRNewswire-Asia-FirstCall/ -- China ... "the Company"), the largest,retail drugstore chain in China based on ... results for the quarter ended,June 30, 2009. , ... January 2009, Nepstar terminated a voting rights assignment agreement,which assigned ...
... ... everyone else in New York, personal injury attorneys included, know about drops hidden by those metal ... New York, NY (PRWEB) ... and New York personal injury attorneys would have to agree. It,s extremely rare that a person ...
... , , , , ... and MTA: CTIC) announced today that the U.S. Food and Drug ... New Drug Application (NDA) for pixantrone as treatment for relapsed or ... (PDUFA) date will be established by the FDA regarding the review ...
Cached Medicine News:Health News:Just Out: A Little Piece of Paper That Helps Stop the Spread of Flu! 2Health News:Oregon Company Launches National Campaign to Help Protect People with Intellectual Disabilities from the Swine Flu 2Health News:Battling Inflammation Through Food an Emerging Field 2Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 2Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 3Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 4Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 5Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 6Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 7Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 8Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 9Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 10Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 11Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 12Health News:China Nepstar Chain Drugstore Reports Second Quarter 2009 Financial Results 13Health News:A Miracle Man's 30-Foot Fall Leave New York Personal Injury Attorneys Believing in Miracles, too 2Health News:FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone 2Health News:FDA Accepts to File Cell Therapeutics' New Drug Application for Pixantrone 3
... The 201 DM systems bring modern Data ... by means of a wide range of ... be made to prompt the operator for ... required information during analysis. This data can ...
... Glucose 201+ is the latest addition to the ... versions, the new system combines the precision and ... turn around time and ease of use. The ... QC results, together with date and time for ...
... BD ColorPAC Toxin A C. difficile Rapid ... in as little as 10 minutes. When it ... wait. For any laboratory that performs only a ... suspected C. difficile samples for testing, ColorPAC Toxin ...
Clostridium difficile Toxin A Rapydtest® is a fast, simple and highly sensitive test for the rapid and reliable detection of C. difficile Toxins A in faeces....
Medicine Products: